These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 413526)
1. Ileal bypass in the control of hyperlipidemia and atherosclerosis. Scott HW Arch Surg; 1978 Jan; 113(1):62-70. PubMed ID: 413526 [No Abstract] [Full Text] [Related]
2. Ileal bypass in treatment of hyperlipidemia: rationale and present status. Gomes MM; Bernatz PE; Kottke BA; Juergens JL; Titus JL Mayo Clin Proc; 1970 Mar; 45(3):229-41. PubMed ID: 4985180 [No Abstract] [Full Text] [Related]
3. Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys. Younger RK; Curtis JJ; Butts WH; Scott HW South Med J; 1976 Sep; 69(9):1141-2, 1145. PubMed ID: 823644 [TBL] [Abstract][Full Text] [Related]
5. Diet and drug treatment of hyperlipidemia and atherosclerosis. Kuo PT Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101 [No Abstract] [Full Text] [Related]
6. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy. Casdorph HR Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092 [No Abstract] [Full Text] [Related]
7. Surgical treatment of hyperlipidemia. I. Apologia. Buchwald H; Moore RB; Varco RL Circulation; 1974 May; 49(5 Suppl):I1-12. PubMed ID: 4596500 [No Abstract] [Full Text] [Related]
8. Protective effects of ileal bypass on autogenous vein grafts in dogs on atherogenic regimen. Lanier VC; Finch WT; Younger RK; Scott HW Surg Forum; 1972; 23(0):133-5. PubMed ID: 4671051 [No Abstract] [Full Text] [Related]
9. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. Grundy SM; Ahrens EH; Salen G J Lab Clin Med; 1971 Jul; 78(1):94-121. PubMed ID: 5569253 [No Abstract] [Full Text] [Related]
14. Treatment of type II and type IV Fredrickson's hyperlipoproteinemia. Crepaldi G; Fellin R; Briani G Adv Exp Med Biol; 1973; 38():199-217. PubMed ID: 4766527 [No Abstract] [Full Text] [Related]
15. [Hyperlipidemia and coronary disease]. Krikler DM Coeur Med Interne; 1976; 15(1):3-10. PubMed ID: 793762 [No Abstract] [Full Text] [Related]
16. Do fats matter. Jepson EM Trans Med Soc Lond; 1972; 88():12-21. PubMed ID: 4665812 [No Abstract] [Full Text] [Related]
17. Animal models for the study of progression and regression of atherosclerosis. DePalma RG; Insull W; Bellon EM; Roth WT; Robinson AV Surgery; 1972 Aug; 72(2):268-78. PubMed ID: 4626292 [No Abstract] [Full Text] [Related]
18. Corrective therapy of atherogenic hyperlipemia. de Gennes JL; Turpin G; Truffert J; Labrousse B Acta Cardiol; 1972; ():Suppl 15:115-3. PubMed ID: 4542781 [No Abstract] [Full Text] [Related]
19. Xanthomatosis and hyperlipoproteinemia; a review. Polano MK Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111 [No Abstract] [Full Text] [Related]
20. [Diet and drug therapy of hyperlipoproteinemia]. Sirtori C Minerva Med; 1975 Nov; 66(79):4184-5. PubMed ID: 1196507 [No Abstract] [Full Text] [Related] [Next] [New Search]